Each row is a drug, each column a cancer subtype. Cells show the strongest known association for that drug in that cancer: approved clinical trial or blank. The repositionable flag means the drug appears as a synthetic-lethal repositioning candidate in cansar; it’s gene-level, not cancer-level.
| Drug | Target | Relationship | GBM | LUAD | SCLC | LUSC | OAC | OSCC | PDAC | Reposition | #cancers |
|---|---|---|---|---|---|---|---|---|---|---|---|
| biospecimen collection, computed tomography, devimistat, fluorouracil, gemcitabine hydrochloride, hydroxychloroquine, magnetic resonance imaging | ACE2 | SSL via ACE2 | 2 | ||||||||
| 3-dimensional conformal radiation therapy, intensity-modulated radiation therapy (imrt), temozolomide, chloroquine, tumor treating fields therapy (ttf) | ACE2 | SSL via ACE2 | 1 | ||||||||
| binimetinib, hydroxychloroquine | ACE2 | SSL via ACE2 | 1 | ||||||||
| chloroquine | ACE2 | SSL via ACE2 | 1 | ||||||||
| chloroquine, radiotherapy, temozolomide | ACE2 | SSL via ACE2 | 1 | ||||||||
| cobimetinib, hydroxychloroquine, atezolizumab | ACE2 | SSL via ACE2 | 1 | ||||||||
| gemcitabine, abraxane, hydroxychloroquine | ACE2 | SSL via ACE2 | 1 | ||||||||
| gemcitabine, hydroxychloroquine, nab-paclitaxel, paricalcitol | ACE2 | SSL via ACE2 | 1 | ||||||||
| hydroxychloroquine, gemcitabine | ACE2 | SSL via ACE2 | 1 | ||||||||
| hydroxychloroquine, radiotherapy | ACE2 | SSL via ACE2 | 1 | ||||||||
| hydroxychloroquine, temozolomide, pharmacological study, radiation | ACE2 | SSL via ACE2 | 1 | ||||||||
| paclitaxel protein bound, gemcitabine, cisplatin, hydroxychloroquine | ACE2 | SSL via ACE2 | 1 | ||||||||
| paricalcitol, hydroxychloroquine, losartan, neoadjuvant therapy and surgery only (control) | ACE2 | SSL via ACE2 | 1 |